ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) shares traded down 0.3% on Friday . The stock traded as low as $5.81 and last traded at $5.98. 27,030 shares traded hands during mid-day trading, a decline of 18% from the average session volume of 33,069 shares. The stock had previously closed at $6.00.
ENDRA Life Sciences Price Performance
The stock has a market cap of $3.21 million, a PE ratio of -0.01 and a beta of 0.52. The firm’s 50 day moving average price is $5.74 and its two-hundred day moving average price is $1,963.01.
About ENDRA Life Sciences
ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
Further Reading
- Five stocks we like better than ENDRA Life Sciences
- How to Invest in Biotech Stocks
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Overbought Stocks Explained: Should You Trade Them?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
